PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ARKF vs. ARKG
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between ARKF and ARKG is 0.77, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.


-0.50.00.51.00.8

Performance

ARKF vs. ARKG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ARK Fintech Innovation ETF (ARKF) and ARK Genomic Revolution Multi-Sector ETF (ARKG). The values are adjusted to include any dividend payments, if applicable.

-20.00%-10.00%0.00%10.00%20.00%30.00%40.00%AugustSeptemberOctoberNovemberDecember2025
36.97%
-8.12%
ARKF
ARKG

Key characteristics

Sharpe Ratio

ARKF:

1.92

ARKG:

-0.41

Sortino Ratio

ARKF:

2.51

ARKG:

-0.36

Omega Ratio

ARKF:

1.32

ARKG:

0.96

Calmar Ratio

ARKF:

0.93

ARKG:

-0.21

Martin Ratio

ARKF:

7.96

ARKG:

-0.76

Ulcer Index

ARKF:

7.19%

ARKG:

21.92%

Daily Std Dev

ARKF:

29.75%

ARKG:

40.24%

Max Drawdown

ARKF:

-78.63%

ARKG:

-80.10%

Current Drawdown

ARKF:

-37.85%

ARKG:

-78.43%

Returns By Period

In the year-to-date period, ARKF achieves a 6.69% return, which is significantly higher than ARKG's 2.40% return.


ARKF

YTD

6.69%

1M

2.60%

6M

36.97%

1Y

56.12%

5Y*

9.18%

10Y*

N/A

ARKG

YTD

2.40%

1M

1.82%

6M

-8.12%

1Y

-16.37%

5Y*

-6.81%

10Y*

1.48%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


ARKF vs. ARKG - Expense Ratio Comparison

Both ARKF and ARKG have an expense ratio of 0.75%.


ARKF
ARK Fintech Innovation ETF
Expense ratio chart for ARKF: current value at 0.75% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.75%
Expense ratio chart for ARKG: current value at 0.75% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.75%

Risk-Adjusted Performance

ARKF vs. ARKG — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ARKF
The Risk-Adjusted Performance Rank of ARKF is 6363
Overall Rank
The Sharpe Ratio Rank of ARKF is 7474
Sharpe Ratio Rank
The Sortino Ratio Rank of ARKF is 6969
Sortino Ratio Rank
The Omega Ratio Rank of ARKF is 6767
Omega Ratio Rank
The Calmar Ratio Rank of ARKF is 4040
Calmar Ratio Rank
The Martin Ratio Rank of ARKF is 6363
Martin Ratio Rank

ARKG
The Risk-Adjusted Performance Rank of ARKG is 44
Overall Rank
The Sharpe Ratio Rank of ARKG is 33
Sharpe Ratio Rank
The Sortino Ratio Rank of ARKG is 44
Sortino Ratio Rank
The Omega Ratio Rank of ARKG is 44
Omega Ratio Rank
The Calmar Ratio Rank of ARKG is 33
Calmar Ratio Rank
The Martin Ratio Rank of ARKG is 44
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ARKF vs. ARKG - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for ARK Fintech Innovation ETF (ARKF) and ARK Genomic Revolution Multi-Sector ETF (ARKG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for ARKF, currently valued at 1.92, compared to the broader market0.002.004.001.92-0.41
The chart of Sortino ratio for ARKF, currently valued at 2.51, compared to the broader market0.005.0010.002.51-0.36
The chart of Omega ratio for ARKF, currently valued at 1.32, compared to the broader market0.501.001.502.002.503.001.320.96
The chart of Calmar ratio for ARKF, currently valued at 0.93, compared to the broader market0.005.0010.0015.0020.000.93-0.21
The chart of Martin ratio for ARKF, currently valued at 7.96, compared to the broader market0.0020.0040.0060.0080.00100.007.96-0.76
ARKF
ARKG

The current ARKF Sharpe Ratio is 1.92, which is higher than the ARKG Sharpe Ratio of -0.41. The chart below compares the historical Sharpe Ratios of ARKF and ARKG, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00AugustSeptemberOctoberNovemberDecember2025
1.92
-0.41
ARKF
ARKG

Dividends

ARKF vs. ARKG - Dividend Comparison

Neither ARKF nor ARKG has paid dividends to shareholders.


TTM20242023202220212020201920182017
ARKF
ARK Fintech Innovation ETF
0.00%0.00%0.00%0.00%0.00%0.37%1.25%0.00%0.00%
ARKG
ARK Genomic Revolution Multi-Sector ETF
0.00%0.00%0.00%0.00%0.62%0.85%3.14%1.94%1.34%

Drawdowns

ARKF vs. ARKG - Drawdown Comparison

The maximum ARKF drawdown since its inception was -78.63%, roughly equal to the maximum ARKG drawdown of -80.10%. Use the drawdown chart below to compare losses from any high point for ARKF and ARKG. For additional features, visit the drawdowns tool.


-80.00%-70.00%-60.00%-50.00%-40.00%-30.00%AugustSeptemberOctoberNovemberDecember2025
-37.85%
-78.43%
ARKF
ARKG

Volatility

ARKF vs. ARKG - Volatility Comparison

The current volatility for ARK Fintech Innovation ETF (ARKF) is 11.14%, while ARK Genomic Revolution Multi-Sector ETF (ARKG) has a volatility of 13.39%. This indicates that ARKF experiences smaller price fluctuations and is considered to be less risky than ARKG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


6.00%8.00%10.00%12.00%14.00%16.00%AugustSeptemberOctoberNovemberDecember2025
11.14%
13.39%
ARKF
ARKG
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab